INNOVADERM CRO IS NOW INDERO.
READ THE ANNOUNCEMENT

TRANSLATION

Talk to us
circle

About Us

Innovaderm is now Indero, a dual-focus CRO dedicated to advancing dermatology and rheumatology therapies through expert, end-to-end clinical research. Explore our history and meet our leadership team.

Reinventing Dermatology & Rheumatology Care

Indero takes a holistic approach to clinical research, merging expertise in dermatology and rheumatology to deliver innovative solutions for immune-mediated inflammatory diseases. Our dedicated team tackles the complexities of trials with a patient-centered focus, turning challenges into opportunities.

Dermatology Expertise

Rheumatology Expertise
sara panchev head shot

Sara Penchev

Director of Clinical Operations at BioMimetix JV, LLC
BioMimetix Logo
“Thanks to Indero’s adaptive approach, we sailed through our trial with ease.”

Our History

Indero is one of three brands (Indero, Innovaderm, and Clinago) working together to advance dermatology and rheumatology research. Each pillar contributes in its own unique way to drive progress in immune-mediated inflammatory diseases.

Innovaderm is our dedicated clinical research site for high-quality, hands-on studies. Equipped with the infrastructure and resources essential for dermatology trials, this unit sets the foundation for precise, impactful research.

As a dual-focus CRO, Indero brings decades of expertise to each clinical trial phase. Specializing in dermatology and rheumatology, our team ensures trials are conducted to the highest standards, meeting the demands of immune-mediated inflammatory disease studies.

Clinago, our proprietary patient recruitment platform, provides reliable, accelerated participant enrollment for dermatology and rheumatology studies. Leveraging an expansive patient network, Clinago shortens recruitment timelines, helping clients achieve their study goals.

2000

Innovaderm Founding

Innovaderm began as a clinical research site specializing in dermatology, quickly earning a reputation for quality research and participant care.

2004

Established Strategic Partnerships

Innovaderm formed strategic alliances with research centers across North America, expanding access to high-quality dermatology sites.

2005

Expanded Management Services and Transition to CRO

Evolved into a Clinical Research Organization (CRO) initiating the management of Investigator-Initiated Studies (IIS), cosmetics, and Phase I topical studies, enhancing service offerings.

2014

Focus on Multicenter Studies

Strengthened CRO activities aimed at multicenter studies, enhancing operational efficiency and research outcomes.

2017

Introduction to Biostatistics

Added biostatistics services and launched first studies in Europe.

2021

Global Expansion

Innovaderm established CRO operations in Europe.

2022

Acquisition of Excelsus Statistics

Acquired Excelsus Statistics, enhancing biometrics capabilities across various therapeutic areas

2024

Expanding & Embracing Rheumatology

We expanded our clinical expertise, now boasting European operational hubs in Poland, Spain, Germany with operational capabilities to conduct trials all across Europe. We also launched enhanced regulatory and clinical development consultation services. 

Our Values

At Indero, our values fuel our commitment to excellence in clinical research. We collaborate, leveraging decades of expertise to support your goals. We embrace innovation, consistently redefining what’s possible in dermatology and rheumatology. With a proactive focus on clients, patients, and sites, we’re not just advancing science—we’re making a meaningful impact in healthcare. We champion cross-functional teamwork, acting with awareness and responsibility. By fostering a safe and collaborative environment, we empower our team to take decisive action. This dedication to personal accountability ensures we deliver the best solutions swiftly and efficiently.
circle

Smarter Together

Seek Out Innovation

Frontline Focus

Dare to Take Action

Philanthropy

At Indero, we are dedicated to philanthropy to improve patients’ health and quality of life. In the past 5 years Indero and parent companies have donated several million dollars to research institutes and universities for the advancement of academic medical research.

Our commitment to innovation and patient care makes Indero a place where meaningful impacts are made every day.

A female doctor sits at her desk and chats to an elderly female patient while looking at her test results

Meet Indero's Executive Team

Robert Bissonnette, head shot

Dr. Robert Bissonnette
MD, MSc, FRCPC

Executive Chairman & Founder

Read BIo

Jeff Smith

Chief Executive
Officer

Read BIo
Dr. Jasmina Jankicevic head shot

Dr. Jasmina Jankicevic
MD, MSc, CCRP

Chief Medical and Scientific Officer

Read BIo
Jason Shuris head shot

Jason Shuris

Chief Business
Officer
Read BIo

Stéphane Lussier

Chief Financial
Officer

Read BIo

Anne Marie Gaulin

Executive VP,

International Expansion

Read BIo

Ina Zschocke

Executive VP, European Operations & Strategy

Read BIo
Diane Leclerc head shot

Diane Leclerc

Vice President,

CRO Operations

Read BIo

Pina D'Angelo

Vice President,

Biometrics

Read BIo
Guillaume Gigon head shot

Guillaume Gigon

Vice President,

Technology and AI

Read BIo
Mélanie Pomerleau head shot

Mélanie Pomerleau

Vice President,

Quality and Compliance

Read BIo
Yvon Leduc head shot

Yvon Leduc

Vice President,

Human Resources

Read BIo

Join The Team.
We’re all in.

Impactful science requires expertise, passion, and a relentless pursuit of excellence. Together, we tackle the complexities of clinical trials, ensuring every study achieves the best possible outcomes. 

If you’re ready to contribute to meaningful advancements in clinical research, we want you on our team.

EXPLORE OUR CAREERS

Talk To Us

Ready to take the next step in dermatology and rheumatology research? Let’s transform the future of immune-mediated inflammatory disease treatment together.

CONTACT US

3530 Saint-Laurent Boulevard
Suite 300

Montreal, QC, H2X 2V1, Canada

Operational Capabilities
  • North America
  • Europe
  • Asia Pacific
  • Latin America
EXPERTISE
OTHER THERAPEUTIC AREAS
STAGES
CRO SERVICES
About
Youtube X-twitter Linkedin

© 2025 Indero. All Rights Reserved. Privacy Policy. Designed and developed by Altitude Marketing.

Robert Bissonnette, MD, FRCPC

Executive Chairman and founder

Dr. Robert Bissonnette is the Executive Chairman and founder of Indero. Dr. Bissonnette has conducted nearly 200 studies ranging from proof-of-concept to phase III. As a Key Opinion Leader, he has extensive knowledge of clinical dermatology, clinical research and the dermatology market. He has published over 270 articles and book chapters and gives lectures on various aspects of dermatology at national and international conferences. After receiving his medical degree from the University of Montreal, he completed his residency training in dermatology followed by his clinical research training at McGill University and the University of British Columbia. Dr. Bissonnette served as an associate professor of dermatology at the University of Montreal until 2004. He is regularly invited to advisory board meetings to share his expert opinion on clinical product development. Dr. Bissonnette is internationally renowned for his clinical expertise in atopic dermatitis and psoriasis.

Jeff Smith

Chief Executive Officer

Jeff Smith, CEO of Indero, brings nearly 30 years of experience in the pharmaceutical and CRO industry, having distinguished himself through exceptional leadership, strategic vision, and innovation. Jeff’s expertise spans global operations, growth management, and fostering a collaborative corporate culture. His strengths in value creation, partner management, and CRO operations have consistently driven success in his previous roles. Under Jeff’s leadership, Indero continues to expand its capabilities, advancing medical knowledge and new therapies in dermatology and rheumatology. Jeff prioritizes purpose, people, and profitability to drive high performance and organizational excellence.

Jasmina Jankicevic, MD, MSc, CCRP

Chief Medical and Scientific Officer

Dr. Jasmina Jankicevic is globally recognized as a thought leader in dermatology & medical aesthetics drug/device development. She has led clinical development in dermatology and medical aesthetics for CROs, pharma/biotech, medical device, and cosmetic companies. She has driven program strategy and implementation of 350+ clinical study protocols in 30+ indications while leading global cross-functional teams towards successful regulatory submissions, product launches, and innovative lifecycle management. As a global expert in dermatology clinical development, Dr. Jankicevic has served as advisor to multiple companies on their way to global regulatory and commercial success of innovative therapeutic solutions for common and rare skin diseases, and aesthetic disorders. Dr. Jankicevic holds Doctor of Medicine degree, Master of Medical Sciences degree, and Board-certification in Dermatology and Venereology from the University of Belgrade, Serbia. She is also a Certified Clinical Research Professional, and a trained journalist. Dr. Jankicevic is a sought-after speaker, and author of numerous articles in peer-reviewed and trade journals.

Jason Shuris

Chief Business Officer

Jason Shuris served as Indero’s Vice President of Business Development from 2018-2021. Following a short leave, he returned to Indero in August 2022 as Chief Business Officer. Jason oversees the sales and marketing activities at the organization. In addition, he plays a key role in strategy planning and execution. Jason began his career in finance, occupying different roles in the accounting departments of privately held hospitals in Boston. He then worked in the life sciences sector as the controller at several biotechnology companies before entering the CRO industry in 2011. To date, he has held various leadership positions at ophthalmology and dermatology-focused CROs. Jason holds a Master of Science in Accounting from Bentley University (MA).

Stéphane Lussier

Chief Financial Officer

Stéphane Lussier joined Indero in 2020 and is currently the Chief Financial Officer. His responsibilities include the management of external and internal accounting, financial reporting and planning and tax analysis. Stéphane has 20+ years of leadership experience in finance and operations in medium-sized and large enterprises. His previous roles include, senior director of finance for the Canadian business division of a US-based publicly traded company in the aeronautic industry. Stephane holds a bachelor’s degree in Business Administration from the Université du Québec à Montréal. He is also a Certified Public Accountant (CPA-CMA).

Anne Marie Gaulin

Executive VP, International Expansion

Anne Marie Gaulin is responsible for the creative vision and strategic plan of action for Indero’s European Expansion initiative. Based in Europe, she will develop the region’s clinical trial activities and expertise. Anne Marie joined Indero in 2009 as the director of business development. A strategic thinker, she greatly contributed to the success and growth of the company by managing sales, marketing, recruitment, operations and commercial development. Anne Marie’s sound knowledge of clinical trials in dermatology and 25+ years’ experience in the pharmaceutical industry fostered strong relationships with our clients. Prior to joining Indero, she worked in business development at Cirion Biopharma, served as an operations manager at Alcan Packaging, and occupied different roles in sales and marketing at Rhône-Poulenc Rorer (now Sanofi) and Sandoz Consumer Health, a division of Novartis.

Ina Zschocke

Executive Vice President, European Operations and Strategy

Ina Zschocke brings over 20 years of clinical research expertise in dermatology, allergology, and aesthetics. As Vice President of European Expansion at Indero, she drives strategic growth and innovation. Previously, Ina served as the head of Dermatology, Immunology, and Inflammatory Diseases, where she developed strategies for high-quality clinical trials. Known for her strategic vision and leadership in complex trials, Ina ensures excellent outcomes for emerging biopharma clients. At Indero, she continues to expand the company’s capabilities in dermatology research, demonstrating her commitment to advancing medical knowledge and new therapies through her strategic approach and dedication to excellence.

Diane Leclerc

VP, CRO Operations

Diane is a seasoned executive leader with over 25 years in clinical and project delivery within CRO, biotechnology, and biopharmaceutical sectors. As head of Project Management and Clinical Operations, she oversees Early Phase and Translational Research, Late-Phase Project Management, Clinical Trial Management, and Clinical Monitoring. Her global team spans the Americas, Europe, and Asia, showcasing her ability to lead diverse teams. Diane excels in managing complex clinical programs, fostering client partnerships, and delivering value-driven outcomes. She has expertise in all phases of clinical drug development and medical devices, with experience in various therapeutic areas. Diane holds a Nursing Sciences degree from Laval University and certifications from SOCRA and PMI. Currently pursuing an Executive MBA, she is dedicated to enhancing her strategic capabilities and driving innovation in clinical research and operations.

Pina D'Angelo

VP, Biometrics

Pina D’Angelo holds a master’s degree in Mathematics and Statistics from McGill University. She has worked in the pharmaceutical industry for over 25 years, both on the generic as well as on the innovator side. Pina has extensive experience in many therapeutic areas in clinical trials ranging from Phase 1 to 4 studies to PK/PD and bioequivalence studies. She has also served as a lecturer of statistics for at various colleges and universities in Montreal and Toronto.

Guillaume Gigon

VP, Technology and AI

Guillaume Gigon joined Indero in 2018 and is currently the Vice President of Technology and AI. Throughout his career, he has held different positions including managing director at a large CRO. Guillaume has 15+ years’ experience in the clinical trial and biomedical industries, including project management and validation. He holds a Master of Science in Biochemistry, a DESS in Information Technology and multiple certifications including Certified CSTB Tester, LSS Green Belt and Portfolio Management.

Mélanie Pomerleau

VP, Quality and Compliance

Mélanie Pomerleau joined Indero in 2018 as Director, Quality Assurance. For the past four years, she has held the position of Senior Director, Quality and Compliance. Mélanie has over 25 years of experience in the pharmaceutical industry, with a focus on clinical research. She has served as a quality assurance manager in large CROs in both Canada and the United States (Phase I and II). Additionally, she was the Head of Clinical Quality for a small-sized pharmaceutical company specialized in women’s health where she was actively involved in phase III studies and post-approval monitoring.

Yvon Leduc

VP, Human Resources

Yvon Leduc serves as the Vice President of Human Resources at Indero. His responsibilities include developing strategies, establishing programs and setting goals for the department while fostering a diverse workplace that allows employees to flourish. Yvon has 25+ years of leadership experience in human resources management. Prior to joining Indero, he was a Senior Director of Human Resources at a global pharmaceutical company. Yvon holds a bachelor’s degree in Industrial Relations from the University of Montreal. He also holds the designation of Chartered Professional in Human Resources (CPHR) from Quebec.

logo mobile
Talk to us

Is Now

We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Innovaderm will continue to operate as a CRU for dermatology studies.

Site Selection & Management

Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.

SEE SERVICES
Hands, tablet and contact us with healthcare marketing or advertising on a website in the medical industry.

Patient Recruitment

Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.

SEE SERVICES

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.

SEE SERVICES
PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.

SEE SERVICES
Talk to us